DJ Catalyst Pharmaceuticals Inc. Stock Underperforms Thursday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Catalyst Pharmaceuticals Inc. $(CPRX)$ slid 2.10% to $22.33 Thursday, on what proved to be an all-around dismal trading session for the stock market, with the NASDAQ Composite Index falling 0.28% to 22,090.69 and Dow Jones Industrial Average falling 0.44% to 46,021.43.
This was the stock's second consecutive day of losses.
Catalyst Pharmaceuticals Inc. closed 15.99% short of its 52-week high of $26.58, which the company reached on June 9th.
The stock underperformed when compared to some of its competitors Thursday, as Johnson & Johnson $(JNJ)$ rose 0.13% to $237.60, Pfizer Inc. $(PFE)$ rose 0.33% to $27.41, and Abbott Laboratories $(ABT)$ fell 1.20% to $107.19.
Trading volume (1.0 M) remained 210,484 below its 50-day average volume of 1.2 M.
Data source: Dow Jones Market Data, FactSet. Data compiled March 19, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
March 19, 2026 17:23 ET (21:23 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.
